Boston Trust Walden Corp Amgen Inc Transaction History

Boston Trust Walden Corp

$14.1 Billion
Q3 2024

A detailed history of Boston Trust Walden Corp transactions in Amgen Inc stock. As of the latest transaction made, Boston Trust Walden Corp holds 38,780 shares of AMGN stock, worth $12.3 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

38,780

Previous 42,710 9.2%

Holding current value

$12.3 Million

Previous $13.3 Million 6.36%

% of portfolio

0.09%

Previous 0.1%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$309.38 - $337.38 $1.22 Million - $1.33 Million	-3,930 Reduced 9.2%	38,780 $12.5 Million
Q2 2024 Jul 19, 2024	SELL	$262.75 - $319.31 $233,847 - $284,185	-890 Reduced 2.04%	42,710 $13.3 Million
Q1 2024 Apr 22, 2024	SELL	$268.87 - $324.56 $16,132 - $19,473	-60 Reduced 0.14%	43,600 $12.4 Million
Q4 2023 Jan 24, 2024	SELL	$255.7 - $288.46 $74,153 - $83,653	-290 Reduced 0.66%	43,660 $12.6 Million
Q3 2023 Oct 18, 2023	BUY	$218.65 - $271.46 $1.02 Million - $1.26 Million	4,650 Added 11.83%	43,950 $11.8 Million
Q2 2023 Jul 24, 2023	SELL	$214.27 - $253.37 $333,189 - $393,990	-1,555 Reduced 3.81%	39,300 $8.73 Million
Q1 2023 Apr 19, 2023	SELL	$225.79 - $275.2 $1.55 Million - $1.89 Million	-6,850 Reduced 14.36%	40,855 $9.88 Million
Q4 2022 Jan 20, 2023	BUY	$229.03 - $291.01 $2.74 Million - $3.48 Million	11,965 Added 33.48%	47,705 $0
Q3 2022 Oct 19, 2022	BUY	$224.46 - $253.15 $270,474 - $305,045	1,205 Added 3.49%	35,740 $8.06 Million
Q2 2022 Jul 22, 2022	SELL	$230.71 - $256.74 $886,387 - $986,395	-3,842 Reduced 10.01%	34,535 $8.4 Million
Q1 2022 Apr 20, 2022	SELL	$219.27 - $242.57 $25.9 Million - $28.6 Million	-117,946 Reduced 75.45%	38,377 $9.28 Million
Q4 2021 Jan 21, 2022	SELL	$198.88 - $227.6 $3.49 Million - $3.99 Million	-17,531 Reduced 10.08%	156,323 $35.2 Million
Q3 2021 Oct 25, 2021	SELL	$212.27 - $248.7 $4.43 Million - $5.19 Million	-20,877 Reduced 10.72%	173,854 $37 Million
Q2 2021 Jul 22, 2021	BUY	$233.58 - $259.14 $1.99 Million - $2.21 Million	8,530 Added 4.58%	194,731 $47.5 Million
Q1 2021 Apr 21, 2021	BUY	$221.91 - $258.6 $5.95 Million - $6.94 Million	26,825 Added 16.83%	186,201 $46.3 Million
Q4 2020 Jan 15, 2021	BUY	$216.38 - $257.67 $3.41 Million - $4.06 Million	15,746 Added 10.96%	159,376 $36.6 Million
Q3 2020 Oct 14, 2020	BUY	$234.65 - $260.95 $30.5 Million - $33.9 Million	129,956 Added 950.39%	143,630 $36.5 Million
Q2 2020 Jul 23, 2020	SELL	$197.81 - $242.74 $9,890 - $12,137	-50 Reduced 0.36%	13,674 $3.23 Million
Q1 2020 Apr 21, 2020	SELL	$182.24 - $241.7 $22,233 - $29,487	-122 Reduced 0.88%	13,724 $2.78 Million
Q4 2019 Jan 10, 2020	SELL	$189.21 - $243.2 $23,272 - $29,913	-123 Reduced 0.88%	13,846 $3.34 Million
Q3 2019 Oct 21, 2019	SELL	$174.11 - $208.62 $63,724 - $76,354	-366 Reduced 2.55%	13,969 $2.7 Million
Q2 2019 Jul 25, 2019	BUY	$166.7 - $195.41 $406,081 - $476,018	2,436 Added 20.47%	14,335 $2.64 Million
Q1 2019 Apr 16, 2019	SELL	$180.87 - $203.88 $714,255 - $805,122	-3,949 Reduced 24.92%	11,899 $2.26 Million
Q4 2018 Jan 17, 2019	SELL	$178.4 - $208.25 $531,632 - $620,585	-2,980 Reduced 15.83%	15,848 $3.09 Million
Q3 2018 Oct 23, 2018	BUY	$185.29 - $208.89 $185,290 - $208,890	1,000 Added 5.61%	18,828 $3.9 Million
Q2 2018 Jul 25, 2018	SELL	$166.05 - $186.51 $7,472 - $8,392	-45 Reduced 0.25%	17,828 $3.29 Million
Q1 2018 Apr 13, 2018	BUY	$169.43 - $198.0 $364,274 - $425,700	2,150 Added 13.67%	17,873 $3.05 Million
Q3 2017 Oct 13, 2017	BUY	$167.29 - $191.0 $2.63 Million - $3 Million	15,723	15,723 $2.93 Million

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.29M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.

Account

Boston Trust Walden Corp Amgen Inc Transaction History